XML 63 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity and Stock Based Compensation Plans
9 Months Ended
Sep. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Equity and Stock Based Compensation Plans
Equity and Stock Based Compensation Plans
Options
The fair value of each option award is estimated on the date of grant using the Black-Scholes valuation model and the assumptions noted in the following table. The expected life of options granted was calculated using the simplified method. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of the Company's stock price. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not intend to pay any cash dividends in the foreseeable future.
 
Three Months Ended
 
Nine Months Ended
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Stock Options
 
 
 
 
 
 
 
Expected life

 
4.6 years

 
4.6 years

 
4.5 years

Expected volatility

 
64.38
%
 
54.86
%
 
71.04
%
Risk-free interest rate

 
1.52
%
 
1.54
%
 
1.00
%
Dividends

 

 

 

Employee Stock Purchase Plan
 
 
 
 
 
 
 
Expected life
0.5 years

 
0.5 years

 
0.5 years

 
0.5 years

Expected volatility
29.64
%
 
25.94
%
 
32.60
%
 
26.75
%
Risk-free interest rate
0.06
%
 
0.10
%
 
0.54
%
 
0.11
%
Dividends

 

 

 


No stock options were awarded during the three months ended September 27, 2014. The weighted average fair value per share of the stock options awarded in the three months September 28, 2013 was $7.75, and in the nine months ended September 27, 2014 and September 28, 2013, was $8.13 and $8.55, respectively, based on the fair market value of the Company’s common stock on the grant dates.
A summary of activity under the Company’s stock option plans during the nine months ended September 27, 2014 is as follows:
 
Number of
Shares
Outstanding
(Options)
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Term (Years)
 
Aggregate Intrinsic Value (in Thousands)
Options:
 
 
 
 
 
 
 
Outstanding at December 28, 2013
1,909,039

 
$
13.22

 
4.02

 
$
10,341

Exercised
(395,940
)
 
$
10.54

 
 
 
 
Granted
74,300

 
$
17.56

 
 
 
 
Cancelled
(104,781
)
 
$
15.64

 
 
 
 
Outstanding at September 27, 2014
1,482,618

 
$
13.98

 
3.65

 
$
3,521

Exercisable at September 27, 2014
1,038,707

 
$
13.03

 
2.92

 
$
3,346

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the Company’s closing stock price of $15.70 as of September 26, 2014, the last trading day of the quarter, which would have been received by the option holders had all option holders exercised their options as of that date. The total intrinsic value of options exercised during the three months ended September 27, 2014 and September 28, 2013, was $0.4 million and $0.2 million, respectively, and during the nine months ended September 27, 2014 and September 28, 2013, was $2.9 million and $1.7 million, respectively.

Restricted Stock Units ("RSUs")
A summary of activity for RSUs during the nine months ended September 27, 2014, is as follows:
 
Number
of RSUs
 
Weighted
Average Fair
Value
Outstanding RSUs at December 28, 2013
334,444

 
$
18.61

    Granted
399,475

 
$
17.61

    Released
(136,959
)
 
$
17.89

    Cancelled
(63,711
)
 
$
16.75

Outstanding RSUs at September 27, 2014
533,249

 
$
18.27


Stock-based Compensation Expense
Stock-based compensation expense for all share-based payment awards made to the Company’s employees and directors pursuant to the employee stock option and employee stock purchase plans by function was as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
September 27,
2014

September 28,
2013
 
September 27,
2014
 
September 28,
2013
Cost of products
$
70

 
$
55

 
$
199

 
$
153

Cost of service
53

 
74

 
227

 
204

Research and development
331

 
412

 
967

 
1,092

Selling
490

 
476

 
1,353

 
1,418

General and administrative
761

 
789

 
2,369

 
2,149

Restructuring

 
896

 

 
896

Total stock-based compensation expense
$
1,705

 
$
2,702

 
$
5,115

 
$
5,912